Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion

Magdy Abdelhamid; Amr Zaki Salem; Hamza Kabil; Hany Ragy; Hosam Hasan-Ali; Mohamed Elnoamany; Mohamed Elsetiha; Sameh Shaheen

doi:10.5334/gh.1411

Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion

Volume 20 (2025): Issue 1

By: Magdy Abdelhamid , Amr Zaki Salem, Hamza Kabil, Hany Ragy, Hosam Hasan-Ali, Mohamed Elnoamany, Mohamed Elsetiha and Sameh Shaheen

Open Access

|Mar 2025

Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology. 2017;14(10):591–602. DOI: 10.1038/nrcardio.2017.65
Open DOI Search in Google Scholar Back to article
Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Heart Failure. 1984;157–180. DOI: 10.1016/S0002-9149(84)80207-6
Open DOI Search in Google Scholar Back to article
Gentile F, Ghionzoli N, Borrelli C, Vergaro G, Pastore MC, Cameli M, et al. Epidemiological and clinical boundaries of heart failure with preserved ejection fraction. European Journal of Preventive Cardiology. 2021;1–11. DOI: 10.1093/eurjpc/zwab077
Open DOI Search in Google Scholar Back to article
Al-Jarallah M, Rajan R, Al-Zakwani I, Dashti R, Bulbanat B, Ridha M, et al. Mortality and morbidity in HFrEF, HFmrEF, and HFpEF patients with diabetes in the middle east. Oman Medical Journal. 2020;35(1):e99. DOI: 10.5001/omj.2020.17
Open DOI Search in Google Scholar Back to article
Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, Kizer JR, et al. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC: Heart Failure. 2018;6(8):678–685. DOI: 10.1016/j.jchf.2018.03.006
Open DOI Search in Google Scholar Back to article
Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Progress in Cardiovascular Diseases. 2005;47(5):320–332. DOI: 10.1016/j.pcad.2005.02.010
Open DOI Search in Google Scholar Back to article
Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. European Journal of Heart Failure. 2011;13(1):18–28. DOI: 10.1093/eurjhf/hfq121
Open DOI Search in Google Scholar Back to article
Tadic M, Cuspidi C, Calicchio F, Grassi G, Mancia G. Diagnostic algorithm for HFpEF: How much is the recent consensus applicable in clinical practice? Heart Failure Review. 2021;26(6):1485–1493. DOI: 10.1007/s10741-020-09966-4
Open DOI Search in Google Scholar Back to article
Gavina C, Carvalho DS, Valente F, Bernardo F, Dinis-Oliveira RJ, Santos-Araújo C, et al. 20 Years of real-world data to estimate the prevalence of heart failure and its subtypes in an unselected population of integrated care units. Journal of Cardiovascular Development and Disease. 2022;9(5):1–14. DOI: 10.3390/jcdd9050149
Open DOI Search in Google Scholar Back to article
Bendary A, Hassanein M, Bendary M, Smman A, Hassanin A, Elwany M. The predictive value of precipitating factors on clinical outcomes in hospitalized patients with decompensated heart failure: Insights from the Egyptian cohort in the European Society of Cardiology Heart Failure long-term registry. The Egyptian Heart Journal. 2023 Mar 8; 75(1):16. DOI: 10.1186/s43044-023-00346-5
Open DOI Search in Google Scholar Back to article
Hassanein M, Abdelhamid M, Ibrahim B, Sobhy M, Nasr G, Aboleineen MW, et al. Gender differences in Egyptian patients hospitalized with heart failure: Insights from the European Society of Cardiology Heart Failure Long-Term Registry. ESC Heart Failure. 2018 Dec; 5(6):1159–1164. DOI: 10.1002/ehf2.12347
Open DOI Search in Google Scholar Back to article
Upadhya B, Kitzman DW. Heart failure with preserved ejection fraction: New approaches to diagnosis and management. Clinical Cardiology. 2020;43(2):145–155. DOI: 10.1002/clc.23321
Open DOI Search in Google Scholar Back to article
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–3726. DOI: 10.1093/eurheartj/ehab368
Open DOI Search in Google Scholar Back to article
Pieske B, Tschöpe C, De Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: The HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Heart Journal. 2019;40(40):3297–3317. DOI: 10.1093/eurheartj/ehz641
Open DOI Search in Google Scholar Back to article
Harper AR, Patel HC, Lyon AR. Heart failure with preserved ejection fraction. Clinical Medicine: Journal of the Royal College of Physicians of London. 2018;18(5):s24–ss29. DOI: 10.7861/clinmedicine.18-2-s24
Open DOI Search in Google Scholar Back to article
Vaidya GN, Abramov D. Echocardiographic evaluation of diastolic function is of limited value in the diagnosis and management of HFpEF. Journal of Cardiac Failure. 2018;24(6):392–396. DOI: 10.1016/j.cardfail.2018.02.008
Open DOI Search in Google Scholar Back to article
Modin D, Andersen DM, Biering-Sørensen T. Echo and heart failure: When do people need an echo, and when do they need natriuretic peptides? Echo Research & Practice. 2018;5(2):R65–R79. DOI: 10.1530/ERP-18-0004
Open DOI Search in Google Scholar Back to article
Van de Bovenkamp AA, Enait V, de Man FS, Oosterveer FT, Bogaard HJ, Vonk Noordegraaf A, van Rossum AC, Handoko ML. Validation of the 2016 ASE/EACVI guideline for diastolic dysfunction in patients with unexplained dyspnea and a preserved left ventricular ejection fraction. Journal of the American Heart Association. 2021 Sep 21; 10(18):e021165. DOI: 10.1161/JAHA.121.021165
Open DOI Search in Google Scholar Back to article
Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA. Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: A simultaneous invasive-echocardiographic study. Circulation. 2017 Feb 28; 135(9):825–838. DOI: 10.1161/CIRCULATIONAHA.116.024822
Open DOI Search in Google Scholar Back to article
Reddy YNV, Obokata M, Egbe A, Yang JH, Pislaru S, Lin G, Carter R, Borlaug BA. Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction. European Journal of Heart Failure. 2019 Jul; 21(7):891–900. Epub 2019 Mar 28. PMID: 30919562. DOI: 10.1002/ejhf.1464
Open DOI Search in Google Scholar Back to article
Huis in ‘t Veld AE, de Man FS, van Rossum AC, Handoko ML. How to diagnose heart failure with preserved ejection fraction: The value of invasive stress testing. Netherlands Heart Journal. 2016;24(4):244–251. DOI: 10.1007/s12471-016-0811-0
Open DOI Search in Google Scholar Back to article
Dzhioeva O, Belyavskiy E. Diagnosis and management of patients with heart failure with preserved ejection fraction (Hfpef): Current perspectives and recommendations. Therapeutics and Clinical Risk Management. 2020;16:769–785. DOI: 10.2147/TCRM.S207117
Open DOI Search in Google Scholar Back to article
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of American College of Cardiology. 2022;79(17):e263–e421.
Search in Google Scholar Back to article
Morfino P, Aimo A, Castiglione V, Vergaro G, Emdin M, Clerico A. Biomarkers of HFpEF: Natriuretic peptides, high-sensitivity troponins and beyond. Journal of Cardiovascular Development and Disease. 2022;9(8). DOI: 10.3390/jcdd9080256
Open DOI Search in Google Scholar Back to article
Lin Y, Fu S, Yao Y, Li Y, Zhao Y, Luo L. Heart failure with preserved ejection fraction based on aging and comorbidities. Journal of Translational Medicine. 2021;19(1):1–13. DOI: 10.1186/s12967-021-02935-x
Open DOI Search in Google Scholar Back to article
Shim CY. Stress testing in heart failure with preserved ejection fraction. Heart Failure Clinics. 2021;17(3):435–445. DOI: 10.1016/j.hfc.2021.02.007
Open DOI Search in Google Scholar Back to article
Van De Bovenkamp AA, Wijkstra N, Oosterveer FP, Vonk Noordegraaf A, Bogaard HJ, Van Rossum AC, De Man FS, Borlaug BA, Handoko ML. The value of passive leg raise during right heart catheterization in diagnosing heart failure with preserved ejection fraction. Circulation: Heart Failure. 2022 Apr;15(4):e008935. DOI: 10.1161/CIRCHEARTFAILURE.121.008935
Open DOI Search in Google Scholar Back to article
Suthahar N, Tschöpe C, de Boer RA. Being in two minds: The challenge of heart failure with preserved ejection fraction diagnosis with a single biomarker. Clinical Chemistry. 2021;67(1):46–49. DOI: 10.1093/clinchem/hvaa255
Open DOI Search in Google Scholar Back to article
Parcha V, Malla G, Kalra R, Patel N, Sanders-van Wijk S, Pandey A, et al. Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems. ESC Heart Failure. 2021;8(3):2089–2102. DOI: 10.1002/ehf2.13288
Open DOI Search in Google Scholar Back to article
Paulus WJ. H2FPEF Score: At last, a properly validated diagnostic algorithm for heart failure with preserved ejection fraction. Circulation. 2018;138(9):871–873. DOI: 10.1161/CIRCULATIONAHA.118.035711
Open DOI Search in Google Scholar Back to article
Reddy YNV, Kaye DM, Handoko ML, van de Bovenkamp AA, Tedford RJ, Keck C, et al. Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea. JAMA Cardiology. 2022 Sep 1;7(9):891–899. PMID: 35830183; PMCID: PMC9280610. DOI: 10.1001/jamacardio.2022.1916
Open DOI Search in Google Scholar Back to article
Reddy YNV, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, et al. Quality of life in heart failure with preserved ejection fraction: Importance of obesity, functional capacity, and physical inactivity. European Journal of Heart Failure. 2020;22(6):1009–1018. DOI: 10.1002/ejhf.1788
Open DOI Search in Google Scholar Back to article
Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE, et al. Comparable performance of the kansas city cardiomyopathy questionnaire in patients with heart failure with preserved and reduced ejection fraction. Circulation: Heart Failure. 2013;6(6):1139–1146. DOI: 10.1161/CIRCHEARTFAILURE.113.000359
Open DOI Search in Google Scholar Back to article
Yee D, Novak E, Platts A, Nassif ME, LaRue SJ, Vader JM. Comparison of the Kansas City cardiomyopathy questionnaire and Minnesota living with heart failure questionnaire in predicting heart failure outcomes. The American Journal of Cardiology. 2019;123(5):807–812. DOI: 10.1016/j.amjcard.2018.11.037
Open DOI Search in Google Scholar Back to article
Napier R, McNulty SE, Eton DT, Redfield MM, AbouEzzeddine O, Dunlay SM. Comparing measures to assess health-related quality of life in heart failure with preserved ejection fraction. JACC Heart Failure. 2018;6(7):552–560. DOI: 10.1016/j.jchf.2018.02.006
Open DOI Search in Google Scholar Back to article
FDA. FDA approves treatment for wider range of patients with heart failure. 2022. p. 5–7.
Search in Google Scholar Back to article
Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, et al. Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial. Circulation. 2021;144(16):1284–1294. DOI: 10.1161/CIRCULATIONAHA.121.056824
Open DOI Search in Google Scholar Back to article
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. The New England Journal of Medicine. 2021;385(16):1451–1461. DOI: 10.1056/NEJMoa2107038
Open DOI Search in Google Scholar Back to article
Heath R, Johnsen H, Strain WD, Evans M. Emerging horizons in heart failure with preserved ejection fraction: The role of SGLT2 inhibitors. Diabetes Therapy. 2022;13(2):241–250. DOI: 10.1007/s13300-022-01204-4
Open DOI Search in Google Scholar Back to article
Rotkvić PG, Berković MC, Bulj N, Rotkvić L, Ćelap I. Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure. World Journal of Diabetes. 2020;11(7):269–279. DOI: 10.4239/wjd.v11.i7.269
Open DOI Search in Google Scholar Back to article
Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. The New England Journal of Medicine. 2022;387(12):1089–1098. DOI: 10.1056/NEJMoa2206286
Open DOI Search in Google Scholar Back to article
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2023 Oct 1; 44(37):3627–3639.
Search in Google Scholar Back to article
Safonova J, Kozhevnikova M, Danilogorskaya Y, Zheleznykh E, Zektser V, Ilgisonis I, et al. Angiotensin-converting enzyme inhibitor therapy effects in patients with heart failure with preserved and mid-range ejection fraction. Cardiology Research. 2021;12(6):363–368. DOI: 10.14740/cr1322
Open DOI Search in Google Scholar Back to article
Solomon SD, Rizkala AR, Gong J, Wang W, Anand IS, Ge J, et al. Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: Rationale and design of the PARAGON-HF trial. JACC Heart Failure. 2017;5(7):471–482. DOI: 10.1016/j.jchf.2017.04.013
Open DOI Search in Google Scholar Back to article
McMurray JJ, Packer M, Desai AS, Rouleau JL, Shi VC, Solomon SD, Swedberg K ZM. Angiotensin–neprilysin inhibition versus enalapril in heart failure. Revista Argentina de Medicina. 2017;5(2):132–133.
Search in Google Scholar Back to article
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, et al. Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction. The New England Journal of Medicine. 2019;381(17):1609–1620. DOI: 10.1056/NEJMoa1908655
Open DOI Search in Google Scholar Back to article
Novartis. Novartis Entresto® granted expanded indication in chronic heart failure by FDA [Internet]. 2021. Available from: https://www.novartis.com/news/media-releases/novartis-entresto-granted-expanded-indication-chronic-heart-failure-fda.
Search in Google Scholar Back to article
Mitter SS, Shah SJ. Spironolactone for management of heart failure with preserved ejection fraction: Whither to after TOPCAT? Current Atherosclerosis Reports. 2015;17(11):64. DOI: 10.1007/s11883-015-0541-6
Open DOI Search in Google Scholar Back to article
Gupta A, Schiros CG, Gaddam KK, Aban I, Denney TS, Lloyd SG, et al. Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy. Journal of Human Hypertension. 2015;29(4):241–246. DOI: 10.1038/jhh.2014.83
Open DOI Search in Google Scholar Back to article
Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, et al. Spironolactone for heart failure with preserved ejection fraction. The New England Journal of Medicine. 2014 Apr 10; 370(15):1383–1392. DOI: 10.1056/NEJMoa1313731
Open DOI Search in Google Scholar Back to article
Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N. Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials. Heart Failure Review. 2021;26(1):165–171. DOI: 10.1007/s10741-020-10013-5
Open DOI Search in Google Scholar Back to article
Bavishi C, Chatterjee S, Ather S, Patel D, Messerli FH. Beta-blockers in heart failure with preserved ejection fraction: A meta-analysis. Heart Failure Review. 2015;20(2):193–201. DOI: 10.1007/s10741-014-9453-8
Open DOI Search in Google Scholar Back to article
Palau P, Seller J, Domínguez E, Sastre C, Ramón JM, de La Espriella R, et al. Effect of β-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction. Journal of American College of Cardiology. 2021;78(21):2042–2056. DOI: 10.1016/j.jacc.2021.08.073
Open DOI Search in Google Scholar Back to article
Infeld M, Wahlberg K, Cicero J, Plante TB, Meagher S, Novelli A, Habel N, Krishnan AM, Silverman DN, LeWinter MM, Lustgarten DL, Meyer M. Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: The myPACE randomized clinical trial. JAMA Cardiology. 2023 Mar 1;8(3):213–221. PMID: 36723919; PMCID: PMC9996402. DOI: 10.1001/jamacardio.2022.5320
Open DOI Search in Google Scholar Back to article
Brubaker PH, Nicklas BJ, Houston DK, Hundley WG, Chen H, Molina AJ, Lyles WM, Nelson B, Upadhya B, Newland R, Kitzman DW. A randomized, controlled trial of resistance training added to caloric restriction plus aerobic exercise training in obese heart failure with preserved ejection fraction. Circulation: Heart Failure. 2023 Feb; 16(2):e010161. DOI: 10.1161/CIRCHEARTFAILURE.122.010161
Open DOI Search in Google Scholar Back to article
Cistulli PA, Malhotra A, Cole KV, Malik AS, Pépin JL, Sert Kuniyoshi FH, Benjafield AV, Somers VK. Positive airway pressure therapy adherence and health care resource use in patients with obstructive sleep apnea and heart failure with preserved ejection fraction. Journal of the American Heart Association. 2023 Jul 18; 12(14):e028733. DOI: 10.1161/JAHA.122.028733
Open DOI Search in Google Scholar Back to article
Chieng, D, Sugumar, H, Segan, L, et al. Atrial fibrillation ablation for heart failure with preserved ejection fraction: A randomized controlled trial. JACC: Heart Failure. 2023 Jun;11(6);646–658. DOI: 10.1016/j.jchf.2023.01.008
Open DOI Search in Google Scholar Back to article
Elasfar A, Shaheen S, El-Sherbeny W, Elsokkary H, Elhefnawy S, Al-Setiha M. Preliminary results of the acute Heart Failure registry in the DELTA region of Egypt (DELTA-HF): A database and a quality initiative project. The Egyptian Heart Journal. 2019;71(1):27. DOI: 10.1186/s43044-019-0024-0
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.5334/gh.1411 | Journal eISSN: 2211-8179

Journal RSS Feed

Language: English

Submitted on: Mar 14, 2024

Accepted on: Feb 24, 2025

Published on: Mar 20, 2025

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

heart failure,

heart failure with preserved ejection fraction,

Egypt,

comorbidities

© 2025 Magdy Abdelhamid, Amr Zaki Salem, Hamza Kabil, Hany Ragy, Hosam Hasan-Ali, Mohamed Elnoamany, Mohamed Elsetiha, Sameh Shaheen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 20 (2025): Issue 1